International Journal of Molecular Sciences· 2026Q1

The NSDHL/c-Myc/PKM2 Axis Drives Glycolytic Reprogramming and Tumor Growth in Multiple Myeloma

Can Yue, Bei-Hui Huang, Lin Qi, Xing‐Ding Zhang et al.

0citations
Q1SCImago
2026year

Short summary

A novel regulatory axis, NSDHL/c-Myc/PKM2, drives tumor growth in multiple myeloma (MM) by increasing glycolysis, with NSDHL upregulation linked to advanced disease and poor survival.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Hematology

HematologyMedicine